Yamaguchi, Japan

Motohisa Shimizu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Motohisa Shimizu: Innovator in Cell Cultivation and Mycobacterial Treatment

Introduction

Motohisa Shimizu is a notable inventor based in Yamaguchi, Japan. He has made significant contributions to the fields of cell cultivation and pharmaceutical compounds, holding a total of 5 patents. His work focuses on innovative solutions that address critical challenges in biotechnology and medicine.

Latest Patents

One of his latest patents is a cell cultivation module that features a polymer porous film and a casing with multiple culture medium inflow/outflow ports. This invention is designed to enhance cell cultivation processes by utilizing a three-layer structure in the polymer porous film. The surface layers have varying hole diameters, allowing for efficient communication with macrovoids, which are essential for optimal cell growth. Another significant patent involves compounds for the treatment of mycobacterial infections, which includes a specific formula or its pharmaceutically acceptable derivatives.

Career Highlights

Motohisa Shimizu has worked with prestigious organizations such as the Broad Institute, Inc. and Massachusetts General Hospital Corporation. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Throughout his career, Shimizu has collaborated with esteemed colleagues, including Deborah Hung and Sarah Stanley. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Motohisa Shimizu's innovative work in cell cultivation and mycobacterial treatment showcases his dedication to advancing biotechnology. His contributions are significant in addressing important medical challenges and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…